Long-term antibiotic treatment for Q fever causes weight gain

Scientists have unearthed still more evidence that antibiotics can contribute to obesity. Research published ahead of print in the journal Antimicrobial Agents and Chemotherapy suggests that patients on long-term antibiotic treatment gained weight and had significant changes in their gut microbiota.

The study, led by Didier Raoult, of Aix-Marseille University, Marseille, France, followed 48 patients who were being treated long-term with doxycycline and for Q fever, and 34 control subjects. Nearly one quarter of the treated patients gained anywhere from two to 13 kg (five to 30 lbs), while none of the controls exhibited . Patients typically received treatment for 18 months.

"Doxycycline and hydroxychloroquine treatment exhibited a reproducible effect on the community structure of the gastrointestinal microbiota, with treated patients presenting significantly lower concentrations of beneficial bacteria, Bacteroidetes, Firmicutes, and Lactobacilli," says coauthor Angelakis Emmanouil, of Unite de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), CNRS, Marseille.

"Reproducible" refers to the fact that the same effect is seen in all the treated patients with weight gain. That strengthens the connection between the diminished numbers of bacterial species and the weight gain.

The finding that one in four patients had weight gain suggests that particular subgroups of patients treated for Q fever are vulnerable to weight gain. In research published last year, Raoult and others showed that the vulnerable subgroups could be predicted by the composition of their prior to .

The investigators conclude that their results highlight the need for reduced calorie diets for undergoing long-term antibiotic treatment, especially with doxycycline.

Q fever causes endocarditis, an infectious inflammation of the inner lining of the heart. Endocarditis can damage the heart valves, and has a high mortality rate.

Hydroxychloroquine is an antimalarial drug that is also used to treat rheumatoid arthritis and lupus erythematosus.

More information: A copy of the manuscript can be found online at aac.asm.org/content/early/2014… 425-13.full.pdf+html . The final version of the article is scheduled for the June 2014 issue of the Antimicrobial Agents and Chemotherapy.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Routines most vital in avoiding Ebola infection: WHO

3 hours ago

Meticulously following stringent routines when putting on and removing protective equipment is more important than the kind of gear health care workers use to ward off Ebola infection, the World Health Organization said Friday.

A look at latest Ebola developments

4 hours ago

No African countries are on the United Nations list of contributors to fight Ebola. With few exceptions, African governments and institutions are offering only marginal support as the continent faces its ...

Liberia opens one of largest Ebola treatment centers

4 hours ago

Remembering those who have died in the world's deadliest Ebola outbreak, Liberia's president opened one of the country's largest Ebola treatment centers in Monrovia on Friday amid hopes that the disease is ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.